Dawson James Downgrades Pluristem Therapeutics (PSTI) to Neutral
Tweet Send to a Friend
Dawson James analyst Jason Kolbert downgraded Pluristem Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
